GovBidAlerts
← All opportunities
This notice has been superseded. See the latest notice: Rivastigmine 24HR Patches (Award Notice)

Rivastigmine 24HR Patches

Key dates

Posted
Aug 22, 2023
Response deadline
—
Archive date
Sep 14, 2028
Archive type
autocustom

Classification

Notice type
Award Notice
Base type
Award Notice
Set-aside
—
Set-aside code
—
PSC
6505

NAICS

  • 325412Pharmaceutical Preparation Manufacturing

    This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Office code
—
Organization type
OFFICE
Office address
PHILADELPHIA, PA, 19111, USA

Place of performance

Street
—
Street 2
—
City
Saint Albans
State
VT
Zip
05478
Country
USA

Contacts

Description

Modification SPE2D222D0147 P00003 to Invoke Option Year 1 for the period of September 14, 2023 through September 13, 2024. Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract. Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract. Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.

Award

Number
SPE2D222D0147
Amount
$10,967,220.00
Date
Sep 14, 2022
Awardee
Mylan Pharmaceuticals Inc. Morgantown WV 26505 USA
UEI
—
Awardee address
—

Other notices in this solicitation

Similar open contracts

Similar past awards

Metadata

Notice ID
bc4f05cccd8541ebadc3df750a514114
Full path
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
Office code
—
Ingested
May 2, 2026
Updated
May 2, 2026
Raw record
{
  "CGAC": "097",
  "City": "PHILADELPHIA",
  "Link": "https://sam.gov/workspace/contract/opp/bc4f05cccd8541ebadc3df750a514114/view",
  "Sol#": "SPE2D221R0113",
  "Type": "Award Notice",
  "State": "PA",
  "Title": "Rivastigmine 24HR Patches",
  "Active": "Yes",
  "Award$": "10967220.00",
  "Office": "DLA TROOP SUPPORT",
  "PopZip": "05478",
  "Awardee": "Mylan Pharmaceuticals Inc. Morgantown WV 26505 USA",
  "PopCity": "Saint Albans",
  "ZipCode": "19111",
  "AAC Code": "SPE2D2",
  "BaseType": "Award Notice",
  "NoticeId": "bc4f05cccd8541ebadc3df750a514114",
  "PopState": "VT",
  "SetASide": "",
  "Sub-Tier": "DEFENSE LOGISTICS AGENCY",
  "AwardDate": "2022-09-14",
  "FPDS Code": "97AS",
  "NaicsCode": "325412",
  "PopCountry": "USA",
  "PostedDate": "2023-08-22 15:27:16.481-04",
  "ArchiveDate": "2028-09-14",
  "ArchiveType": "autocustom",
  "AwardNumber": "SPE2D222D0147",
  "CountryCode": "USA",
  "Description": "Modification SPE2D222D0147 P00003 to Invoke Option Year 1 for the period of September 14, 2023 through September 13, 2024. Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract. Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract. Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.",
  "SetASideCode": "",
  "OrganizationType": "OFFICE",
  "PopStreetAddress": "",
  "ResponseDeadLine": "",
  "PrimaryContactFax": "",
  "AdditionalInfoLink": "",
  "ClassificationCode": "6505",
  "PrimaryContactEmail": "Phyllis.Daraio@dla.mil",
  "PrimaryContactPhone": "2157377941",
  "PrimaryContactTitle": "",
  "SecondaryContactFax": "",
  "Department/Ind.Agency": "DEPT OF DEFENSE",
  "SecondaryContactEmail": "",
  "SecondaryContactPhone": "",
  "SecondaryContactTitle": "",
  "PrimaryContactFullname": "Phyllis Daraio",
  "SecondaryContactFullname": ""
}